Multiplex Assays Market to be Worth $6.80 Billion by 2031

Pharmaceutical & biotechnology companies allocate significant resources for drug discovery & development. The increasing prevalence of chronic diseases is increasing the need for the development of novel therapies, thus focus on drug discovery is increasing. Multiplex assays have become increasingly important in maintaining precision and accuracy in drug research and development and reducing the time required for research purposes. Multiplex assays are used in biomarker discovery and validation. Identifying and characterizing biomarkers can streamline the drug candidate selection process, thus reducing the number of failures in clinical trials and enabling the discovery of more effective therapeutics hence adopted.